Reset Therapeutics
South San Francisco
About Reset Therapeutics
Reset Therapeutics is a biopharmaceutical company formed to discover, develop and commercialize new therapeutics that modulate the circadian system, the body’s network of internal molecular clocks.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $53.6M
- Last round: Series Unknown (Feb 2016)
- Website: resettherapeutics.com
- Phone: (650)235-4150
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/reset-therapeutics-76706 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.